Cargando…
Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma
High recurrence and lower survival rates in patients with oral squamous cell carcinoma (OSCC) are associated with its bone invasion. We identified the oncogenic role of RUNX3 during bone invasion by OSCC. Tumor growth and the generation of osteolytic lesions were significantly inhibited in mice that...
Autores principales: | Park, Junhee, Kim, Hyun-Jeong, Kim, Ki Rim, Lee, Sun Kyoung, Kim, Hyungkeun, Park, Kwang-Kyun, Chung, Won-Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354716/ https://www.ncbi.nlm.nih.gov/pubmed/28030842 http://dx.doi.org/10.18632/oncotarget.14071 |
Ejemplares similares
-
Loss of RUNX3 expression promotes cancer‐associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non‐small cell lung cancer
por: Kim, Hyun‐Jeong, et al.
Publicado: (2015) -
Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts
por: Lee, Sun Kyoung, et al.
Publicado: (2017) -
Type I Saikosaponins A and D Inhibit Osteoclastogenesis in Bone Marrow-Derived Macrophages and Osteolytic Activity of Metastatic Breast Cancer Cells
por: Shin, Ji-Eun, et al.
Publicado: (2015) -
Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis
por: Lee, Sun Kyoung, et al.
Publicado: (2017) -
15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
por: Kim, Ki Rim, et al.
Publicado: (2015)